Study of gemcitabine-sensitive/resistant cancer cells by cell cloning and synchrotron FTIR microspectroscopy

Cytometry Part A

Volumn 85, Issue 8, 2014, Pages 688-697

  Rutter, Abigail V ^a   Siddique, Muhammad R ^a   Filik, Jacob ^b   Sandt, Christophe ^c   Dumas, Paul ^c   Cinque, Gianfelice ^b   Sockalingum, Ganesh D ^d,e   Yang, Ying ^a   Sulé Suso, Josep ^a,f  

^a KEELE UNIVERSITY   (United Kingdom)

^b DIAMOND LIGHT SOURCE LTD   (United Kingdom)

^c SYNCHROTRON SOLEIL   (France)

^d UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^e UFR Sciences Exactes et Naturelles   (France)

^f UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Cell cloning; Fourier transform infrared microspectroscopy; Gemcitabine; Lung cancer; Synchrotron

Indexed keywords

DEOXYCYTIDINE; GEMCITABINE;

ANALOGS AND DERIVATIVES; CELL CLONE; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; INFRARED SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; SYNCHROTRON; TUMOR CELL LINE;

CELL LINE, TUMOR; CLONE CELLS; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; HUMANS; PRINCIPAL COMPONENT ANALYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SYNCHROTRONS;

EID: 84904596785     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22488     Document Type: Article

References (40)

1. Zhang W, Shannon WD, Duncan J, Scheffer GL, Scheper RJ, McLeod HL. Expression of drug pathway proteins is independent of tumour type. J Pathol 2006;209:213-219.
2. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362:362-369.
3. Robert J, Vekris A, Pourquier P, Bonnet J. Predicting drug response based on gene expression. Crit Rev Oncol Hematol 2004;51:205-527.
4. Blumenthal RD, Goldenberg DM. Methods and goals for the use of in vitro and in vivo chemosensitivity testing. Mol Biotechnol 2007;35:185-197.
5. Cree IA. Chemosensitivity and chemoresistance testing in ovarian cancer. Curr Opin Obstet Gynecol 2009;21:39-43.
6. Samson DJ, Seidenfeld J, Ziegler K, Aronson N. Chemotherapy sensitivity and resistance assays: A systematic review. J Clin Oncol 2004;22:3618-3630.
7. Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD, Somerfield MR. ASCO working group on chemotherapy sensitivity and resistance assays. J Clin Oncol 2004;22:3631-3638.
8. Gasparri F, Muzio M. Monitoring of apoptosis of HL60 cells by Fourier Transform Infrared spectroscopy. Biochem J 2003;369:239-248.
9. Sulé-Suso J, Skingsley D, Sockalingum GD, Kohler A, Kegelaer G, Manfait M, El Haj AJ. FTIR microspectroscopy as a tool to assess lung cancer cells response to chemotherapy. Vibrat Spectrosc 2005;38:179-184.
10. Draux F, Jeannesson P, Gobinet C, Sulé-Suso J, Pijanka J, Sandt C, Dumas P, Manfait M, Sockalingum GD. IR spectroscopy evidences effect of non-cytotoxic (cytostatic) doses of antitumor drug on cancer cells. Anal Bioanal Chem 2009;395:2293-2301.
11. Gasper R, Dewelle J, Kiss R, Mijatovic T, Goormaghtigh E. IR spectroscopy as a new tool for evidencing antitumor drug signatures. Biochim Biophys Acta 2009;1788:1263-1270.
12. Bellisola G, Della Peruta M, Vezzalini M, Moratti E, Vaccari L, Birarda G, Piccinini M, Cinque G, Sorio C. Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy. Analyst 2010;135:3077-3086.
13. Derenne A, Verdonck M, Goormaghtigh E. The effect of anticancer drugs on seven cell lines monitored by FTIR spectroscopy. Analyst 2012;137:3255-3264.
14. Machana S, Weerapreeyakul N, Barusrux S, Thumanu K, Tanthanuch W. FTIR microspectroscopy discriminates anticancer action on human leukemic cells by extracts of Pinuskesiya; Cratoxylumformosum ssp. pruniflorum and melphalan. Talanta 2012;93:371-382.
15. Marcisin EJ, Uttero CM, Mazur AI, Miljković M, Bird B, Diem M. Noise adjusted principal component reconstruction to optimize infrared microspectroscopy of individual live cells. Analyst 2012;137:2958-2964.
16. Dumas P, Sockalingum GD, Sulé-Suso J. Adding synchrotron radiation to infrared microspectroscopy: What's new in biomedical applications? Trends Biotechnol 2007;25:40-44.
17. Mohlenhoff B, Romeo M, Wood BR, Diem M. Mie-scattering and non-Beer-Lambert absorption behaviour of human cells in infrared microspectroscopy. Biophys J 2005;88:3635-3640.
18. Romeo M, Diem M. Correction of dispersive line shape artefact observed in diffuse reflection infrared spectroscopy and absorption/reflection (transflection) infrared micro-spectroscopy. Vibrat Spectrosc 2005;38:129-132.
19. Pijanka J, Kohler A, Yang Y, Dumas P, Chio-Srichan S, Manfait M, Sockalingum GD, Sulé-Suso J. Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy. Analyst 2009;134:1176-1181.
20. Kohler A, Sulé-Suso J, Sockalingum GD, Tobin M, Bahrami F, Yang Y, Pijanka J, Dumas P, Cotte M, van Pittius DG, Parkes G, Martens H. Estimating and correcting Mie scattering in synchrotron-based microscopic FTIR spectra by extended multiplicative signal correction (EMSC). Appl Spectrosc 2008;62:259-266.
21. Bassan P, Byrne HJ, Bonnier F, Lee J, Dumas P, Gardner P. Resonant Mie scattering in infrared spectroscopy of biological materials, understanding the dispersion artifact. Analyst 2009;134:1586-1593.
22. Bassan P, Kohler A, Martens H, Lee J, Byrne HJ, Dumas P, Gazi E, Brown M, Clarke N, Gardner P. Resonant Mie Scattering (RMieS) correction of infrared spectra from highly scattering biological samples. Analyst 2010;135:268-277.
23. Bird B, Miljković M, Diem M. Two step resonant Mie scattering correction of infrared micro-spectral data: Human lymph node tissue. J. Biophoton 2010;3:597-608.
24. Grégoire V, Rosier JF, De Bast M, Bruniaux M, De Coster B, Octave-Prignot M, Scalliet P. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. Radiother Oncol 2002;63:329-338.
25. Pijanka J, Sockalingum GD, Kohler A, Yang Y, Draux F, Dumas P, Sandt C, Parkes G, van Pittius DG, Douce G, Untereiner V, Sulé-Suso J. Synchrotron based FTIR spectra of stained single cells. Towards a clinical application in pathology. Lab Invest 2010;90:797-807.
26. Aktipis CA, Nesse RM. Evolutionary foundations for cancer biology. Evol Appl 2013;6:144-159.
27. Moysan E, Bastiat G, Benoit J-P. Gemcitabine versus modified gemcitabine: A review of several promising chemical modifications. Mol Pharmaceutics 2013;10:430-444.
28. Zarcone D, Tilden AB, Friedman HM, Grossi CE. Human leukaemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity. Can Res 1987;47:2674-2682.
29. Liu KZ, Mantsch HH. Apoptosis-induced structural changes in leukemia cells identified by IR spectroscopy. J Mol Struct 2001;565-566:299-304.
30. Zhou J, Wang Z, Sun S, Liu M, Zhang H. A rapid method for detecting conformational changes during differentiation and apoptosis of HL60 cell by Fourier Transform infrared spectroscopy. Biotechnol Appl Biochem 2001;33:127-132.
31. Gaigneaux A, Ruysschaert JM, Goormaghtigh E. Infrared spectroscopy as a tool for discrimination between sensitive and multiresistant K562 cells. Eur J Biochem 2002;269:1968-1973.
32. Jamin N, Dumas P, Moncuit J, Fridman WH, Teillaud JL, Carr GL, Williams GP. Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometry. Proc Natl Acad Sci USA 1998;95:4837-4840.
33. Holman HYN, Martin MC, Blakely EA, Bjornstad K, McKinney WR. IR spectroscopic characteristics of cell cycle and cell death probed by synchrotron radiation based Fourier transform IR spectromicroscopy. Biopolymers 2000;57:329-335.
34. Travo A, Desplat V, Barron E, Poychicot-Coustau E, Guillon J, Déléris G, Forfar I. Basis of a FTIR spectroscopy methodology for automated evaluation of Akt kinase inhibitor on leukemic cell lines used as model. Anal Bioanal Chem 2012;404:1733-1743.
35. Gasper R, Dewelle J, Kiss R, Mijatovic T, Goormaghtigh E. IR spectroscopy as a new tool for evidencing antitumor drug signatures. Biochim Biophys Acta 2009;1788:1263-1270.
36. Zelig U, Kapelushnik J, Moreh R, Mordechai S, Nathan I. Diagnosis of cell death by means of infrared spectroscopy. Biophys J 2009;97:2107-2114.
37. Vileno B, Jeney S, Sienkiewicz A, Marcoux P, Miller L, Forro L. Evidence of lipid peroxydation and protein phosphorylation in cells upon oxydative stress photo-generated by fullerols. Biophys Chem 2010;152:164-169.
38. Fryer RA, Barlett B, Galustian C, Dalgleish AG. Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide. Anticancer Res 2011;31:3747-3756.
39. Bergman AM, Pinedo HM, Peters GJ. Determinants of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine). Drug Resist Update 2002;5:19-33.
40. Draux F, Gobinet C, Sulé-Suso J, Manfait M, Jeannesson P, Sockalingum GD. Raman imaging of single living cells: Probing effects of non cytotoxic doses of an anti-cancer drug. Analyst 2011;136:2718-2725.